KMB
39
2
ISRG
74
-2
XYL
49
4
CA
38
6
DG
6
2
EQIX
64
2
HAS
33
3
SEE
56
6
PBI
69
4
TGT
22
2
NDAQ
62
2
GPC
40
3
AA
48
-12
EFX
38
2
ES
34
3
WFC
79
4
XRAY
28
2
PFE
23
7
SLB
55
2
CCI
31
3
KMB
39
2
ISRG
74
-2
XYL
49
4
CA
38
6
DG
6
2
EQIX
64
2
HAS
33
3
SEE
56
6
PBI
69
4
TGT
22
2
NDAQ
62
2
GPC
40
3
AA
48
-12
EFX
38
2
ES
34
3
WFC
79
4
XRAY
28
2
PFE
23
7
SLB
55
2
CCI
31
3
Financhill
Back

Ocugen Vs. Cytokinetics Industry Stock Comparison

Sell
42

OCGN
Ocugen

Last Price:
0.91
Seasonality Move:
364.7%
Sell
41

CYTK
Cytokinetics

Last Price:
49.09
Seasonality Move:
14.49%
Sell
42
Ocugen (OCGN) is a Sell

Is Ocugen a Buy, Sell or Hold?

  • The current Ocugen [OCGN] share price is $0.91. The Score for OCGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • OCGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $49.10. The Score for CYTK is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OCGN Stock Price Chart

What is Ocugen's stock price today?

  • The Ocugen share price today is $0.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCGN is experiencing slight buying pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $49.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

OCGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 44.59 Sell
Chaikin Money Flow: -234402 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.9 - 1) Sell
Bollinger Bands (100): (0.92 - 1.5) Sell

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.09 Sell
Relative Strength Index (14 RSI): 39.46 Sell
Chaikin Money Flow: 598609 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.21 - 55.57) Sell
Bollinger Bands (100): (52.53 - 57.27) Sell

OCGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.93 Sell
20-day SMA: 0.96 Sell
50-day SMA: 0.98 Sell
200-day SMA: 1.29 Sell
8-day EMA: 0.93 Sell
20-day EMA: 0.95 Sell
50-day EMA: 1.02 Sell
200-day EMA: 1.14 Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.32 Sell
20-day SMA: 52.83 Sell
50-day SMA: 53.63 Sell
200-day SMA: 59.51 Sell
8-day EMA: 50.87 Sell
20-day EMA: 52.43 Sell
50-day EMA: 53.54 Sell
200-day EMA: 55.31 Sell

Ocugen Earnings Growth & OCGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.07 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.07 per share.

Ocugen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):